Rothschild & Co Redburn analyst Issie Kirby upgraded Sonova (SONVY) to Neutral from Sell with a price target of CHF 215, up from CHF 210. The firm says the weaker hearing aid market outlook and heightened competitive landscape are now priced into the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: